Overview

September 25-26: Forum

DIA is thrilled to announce our 2024 Latin America Annual Meeting that will include opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America and the Caribbean. This meeting expands in scope from our previous meetings discussing topics relating to the Latin America region, and presents the following three tracks: Regulatory/Clinical, Safety and Pharmacovigilance, and Medical Affairs and Scientific Communications (MASC). Cross-track sessions provide the opportunity to discuss key connection points across major components of regulatory, clinical, safety, pharmacovigilance, and medical affairs and scientific communications initiatives, efforts and collaboration within these functional areas in an organization or company. Join us to discuss multi-regional cooperation, global harmonization, lessons learned, and best practices to stimulate discussion and foster collaboration amongst stakeholders in Latin America and the Caribbean.

*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this meeting.

While we develop our 2024 agenda, please take a moment to review the 2023 final agenda

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.

Download Letter

Participant Testimonials

The agenda was prepared including topics of great importance and current affairs. The exchange between the participants is very enriching and gives the possibility of listening first-hand to the experience of prestigious speakers. - Lisette Pérez Ojeda - CECMED, Colombia

It is an important event to share information/experiences, to access the current status and opportunities, to develop ourselves and to implement new strategies/skills/information into the work. – Patricia Dias - LEO Pharma, Brazil

Featured

Want to learn more about Latin America Annual Meeting? You've come to the right site!

Who should attend?

Professionals interested in:
- Academia
- Benefit-Risk Assessment and Communication
- Clinical Research and Development
- Clinical Operations
- CROs/Vendors
- Document Management/eSubmissions
- Drug Regulation
- Drug Safety/Pharmacovigilance
- Field Medical
- Global Submission/Project Management
- Government Affairs
- Manufacturing
- Medical and Scientific Affairs
- Medical Call Center Environment
- Medical Communications
- Medical Information
- Medical Product Safety Assessment
- Medical Science Liaisons
- Medical Writing
- Pharmacoepidemiology
- Policy and Intelligence
- Post-Market Studies
- Quality Assurance and Compliance
- Real-World Evidence
- Regulatory Agencies
- Regulatory Affairs, Operations, and Strategy
- Research and Development
- Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
- Strategic Sourcing/Planning

Program Committee

Michelle Arguelles Gonzalez, MBA, RPh, PMP Executive Director, Clinical Research
Merck Sharp & Dohme (MSD), Mexico
Marta Avellar Medical Information Head, Latin America and North America Medical Information
Takeda, Brazil
Josue Bautista, PharmD GCP/PV Auditor
Novartis, Mexico
Daniela Bravo Regulatory Policy and Intelligence Manager
AbbVie, Brazil
Arthur Bueno, MBA Pharmacovigilance Manager
Sanofi, Brazil
Carolina Consuegra, MBA Co-Founder
Science to People, Colombia
Raphael Elmadjian Pareschi, PharmD, MBA Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil
Flavia Firmino Ribeiro, PharmD Director Reg Global CMC
Pfizer, Brazil
Carolina Garcia, PharmD Founder
PGA Farma, Brazil
Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
Roche, Brazil
Susan Koepke, MBA Head of Regulatory Affairs LATAM
EMD Serono, Inc., United States
Lawrence Liberti, PhD, RAC Director, D.K. Kim International Center for Regulatory Science
The Kim Center/ USC DRQS, United States
Mercedes Lopez, MA Regional Operations Manager, Latin America
WCG Clinical, United States
Elkiane Macedo Rama Advisor to the International Affairs Office
Brazilian Health Regulatory Agency (ANVISA), Brazil
Viktoria Magyar, LLM, MSc Doctoral Student, Department of Regulatory and Quality Sciences
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
Rosana M. Mastellaro, PharmD, RPh Director, Technical Regulatory Affairs and Innovation
Sindusfarma, Brazil
Barbara Nardi, PharmD Global Director - Medical Communications
Thermo Fisher Scientific, Brazil
Patricia Oliveira Pereira Tagliari, LLM, MPH Associate Director
ANVISA, Brazil
Lisette Pérez Ojeda Asesora de la Dirección
CECMED, Colombia
Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
FDA, United States
Duglas Rodriguez Calderon, MSc Head of LATAM Regulatory Policy, Global Regulatory Policy & Intelligence
Roche, Panama
Maria Antonieta Tony Roman, MPharm Head Regulatory Policy Emerging Markets LATAM
Novartis, Mexico
Diego Alexander Salas, LLM Regulatory Affairs Director
FEDERACION LATINOAMERICANA DE LA INDUSTRIA FARMACEUTICA, A.C., Mexico
Leonardo Semprun, RPh Global Regulatory Policy Lead-LatAm
MSD, Panama
Ricardo Uribe, MBA Head of Clinical FSPx Americas
Fortrea Clinical Development Mexico, S. De R.L. de C.V., Mexico
Gislaine Villarta Capeleti Dib, PharmD Pharmacovigilance Manager
PGA Farma, Brazil
Susan Zavala Coloma, MS, RPh Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
DIGEMID, Peru
Representative Invited DIA, United States